Celldex Initiates Phase 2 Study of Barzolvolimab in Atopic Dermatitis

GlobeNewswire12/19 21:01

Celldex Therapeutics Doses First Patient in Study of Potential Inflammatory Disease Treatment

MT Newswires11/20 21:56

Beyond The Numbers: 11 Analysts Discuss Celldex Therapeutics Stock

Benzinga11/20 20:00

Founder of Celldex Therapeutics Anthony Marucci Buys 40% More Shares

Simply Wall St11/15 19:17

Celldex Therapeutics to Present at Upcoming Investor Conferences

GlobeNewswire11/12 05:01

Celldex Therapeutics Third Quarter 2024 Earnings: Beats Expectations

Yahoo Finance11/08 18:29